Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.48 -0.01 (-2.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Cash from Investing Activities (2021 - 2023)

Updated

Pasithea Therapeutics (KTTA) posted Cash from Investing Activities of $11,000 for FY2025.

Analysis

Pasithea Therapeutics (KTTA) Cash from Investing Activities (2021 - 2023) Analysis & Trends

Since FY2021, Pasithea Therapeutics has reported Cash from Investing Activities for 4 years.

  • The FY2025 figure stands as the lowest annual Cash from Investing Activities since FY2022.
  • Business Quant data shows KTTA's Cash from Investing Activities at $75,199 in FY2023, -$2.3 million in FY2022 and -$21,503 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Pasithea Therapeutics 16.04 Mn 16.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 54,536.00
Sep 30, 2023 50,159.00
Jun 30, 2023 24,392.00
Mar 31, 2023 -53,888.00
Dec 31, 2022 -2.34 Mn
Sep 30, 2022 -25,967.00
Jun 30, 2022 70,121.00
Mar 31, 2022 -1,951.00
Dec 31, 2021 -12,933.00
API Access

Pasithea Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=KTTA&period=max&api_key=YOUR_API_KEY